Mar 10, 2020 / 07:50PM GMT
Kristen Marie Stewart - Barclays Bank PLC, Research Division - Research Analyst
All right. Well, welcome, everybody, to the Barclays Global Healthcare fireside, beachside, desk-side chat. I'm Kristen Stewart, the medical supplies and device analyst. And it is my pleasure to have Axonics Modulation Technologies here for this lovely session here this afternoon.
With us here today, we have Ray Cohen, company's CEO; as well as Dan Dearen, the CFO.
And we're going to keep this fairly casual. We're going to have a question-and-answer session. (Operator Instructions)
So with that, I'm going to just kind of kick it off to Ray.
Questions and Answers:
Kristen Marie Stewart - Barclays Bank PLC, Research Division - Research AnalystSo Ray, you guys have launched your Axonics Sacral Neuromodulation product here in the United States. You had your commercial launch, I guess, it was the end of October. I was wondering if you could just kind of share with the audience the early perspective that you may have on the launch of the product?
Trustpilot
